Celldex · 21 hours ago
Lead, Payer Strategy & Marketing - Hampton, NJ
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. The Payer Strategy & Marketing leader will be responsible for developing and executing strategies to optimize access, reimbursement, and coverage across key payer channels for a high-priority launch asset.
BiotechnologyHealth CareOncologyPharmaceutical
Responsibilities
Developing comprehensive plans to secure and maintain favorable formulary positioning and reimbursement for products across various payer and distribution channels
Creating clear and compelling messages that highlight the clinical and economic value of products from a payer's perspective
Developing and adapting a range of communication tools, such as product value decks, disease state materials, budget impact models, and digital engagement assets, for payer audiences
Utilizing data and insights to understand payer needs, assess market trends, and inform strategic decision-making
Contributing to the overall launch strategy and managing market access aspects throughout the product's lifecycle
Equipping account teams with the knowledge and resources to effectively engage with payers and communicate value messages
Qualification
Required
Bachelor's degree in marketing, business, or a related field is required
A minimum 7 years of experience in pharmaceutical marketing, with a focus on payer marketing, market access, or account management is required
Travel required up to 10%
Deep Understanding of the US Healthcare System
Payer Landscape: thorough grasp of different payer types (commercial, Medicare, Medicaid, etc.), their decision-making processes, and how they evaluate pharmaceutical products
Reimbursement Models: Familiarity with various reimbursement pathways (buy and bill, specialty pharmacy, etc.) and the intricacies of drug pricing and contracting
Health Economics and Outcomes Research (HEOR): Understanding how to leverage HEOR data to demonstrate a drug's value to payers and inform strategic decisions
Strategic Planning: Developing and executing comprehensive payer marketing strategies aligned with overall brand objectives
Brand Positioning: Effectively communicating the value proposition of a pharmaceutical product to payers
Market Research: Conducting and interpreting market research to understand payer needs and preferences
Channel Management: Experience in various marketing channels (digital, traditional, etc.) and their application to payer audiences
Communication: Strong written and verbal communication skills to effectively convey complex information to both internal and external stakeholders
Collaboration: Building strong relationships with cross-functional teams (sales, market access, medical affairs, etc.) and external partners (payers, providers)
Influence and Persuasion: Ability to influence decision-making processes and secure favorable formulary placements
Leadership: Leading and motivating teams to achieve strategic goals
Problem-Solving: Identifying and addressing challenges related to payer access and reimbursement
Data Analysis: Analyzing market data, payer claims data, and other relevant information to inform strategic decisions
Budget Management: Managing marketing budgets and resources effectively
Financial Acumen: Understanding the financial implications of payer decisions and strategies
Pharmaceutical Regulations: Adhering to relevant pharmaceutical regulations and guidelines in payer marketing activities
Compliance: Ensuring all payer marketing activities are compliant with ethical and legal standards
Preferred
Master's degree, MBA, or other advanced degree is preferred
Benefits
Annual discretionary bonus
Long term incentive
401(K) plan with employer contribution
Health care and other insurance benefits (for employee and family)
Paid holidays
Vacation
Sick days
Company
Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies.
Funding
Current Stage
Public CompanyTotal Funding
$1.54B2024-02-29Post Ipo Equity· $460.5M
2023-11-07Post Ipo Equity· $200.5M
2021-07-12Post Ipo Equity· $287.5M
Leadership Team
Recent News
2025-11-16
Company data provided by crunchbase